April 20, 2024
Market Now
Hanmi Pharma invests W113.5b in factory
[DISCLOSURE] Hanmi Pharmaceutical (128940) announced on Jan. 19 that it will invest 113.3 billion won (US$96.33 million) in manufacturing facilities at its second bio plant in Pyeongtaek, Gyeonggi Province.
The investment is for manufacturing facilities for clinical trials and approvals of new bio medicines and manufacturing of commercialized medicines, said the company.
This amounts to 15.21 percent of its 2015 revenue.
(theinvestor@heraldcorp.com)
The investment is for manufacturing facilities for clinical trials and approvals of new bio medicines and manufacturing of commercialized medicines, said the company.
This amounts to 15.21 percent of its 2015 revenue.
(theinvestor@heraldcorp.com)
